DL-3-Ureidoisobutyric acid

Get a Price/Quote

MOQ : 1 Kilograms

DL-3-Ureidoisobutyric acid Specification

Usage
Ureidoisobutyric acid can be used to predict patient's individual phenotypes of enzyme deficiencies in pyrimidine metabolism when associated with a risk for severe toxicity against the antineoplastic agent 5-fluorouracil (PMID: 12798197 ).

Purity
96%

Molecular Weight
146.146 Grams (g)

Melting Point
177…178 °C

Molecular Formula
C5H10N2O3

DL-3-Ureidoisobutyric acid Trade Information

Minimum Order Quantity
1 Kilograms

Payment Terms
Cash in Advance (CID), Cash Advance (CA)

Supply Ability
500 Kilograms, KG Per Month

Delivery Time
2-8 Week

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
Carton and Poly Bag.

Main Export Market(s)
Western Europe, Australia, Eastern Europe, Central America, Middle East, South America, Asia, North America, Africa

Main Domestic Market
All India

About DL-3-Ureidoisobutyric acid

DL-3-Ureidoisobutyric acid Synonym: -UBA, -Ureidoisobutyric acid, 3-(Carbamoylamino)-2-methylpropanoic acid, 3-Ureido-2-methylpropanoic acid, 3-[(Aminocarbonyl)amino]-2-methylpropanoic acid, N-Carbamoyl-2-methyl--alanine Empirical Formula (Hill Notation): C5H10N2O3 Molecular Weight: 146.14 CAS Number: 2905-86-4 assay 99.0% (HPLC) storage temp. 2-8C

FAQs of DL-3-Ureidoisobutyric acid:

Q: What is the purity of DL-3-Ureidoisobutyric acid?

A: The purity of DL-3-Ureidoisobutyric acid is 96%.

Q: What is the molecular weight of DL-3-Ureidoisobutyric acid?

A: The molecular weight of DL-3-Ureidoisobutyric acid is 146.146 grams (g).

Q: What is the melting point range for DL-3-Ureidoisobutyric acid?

A: The melting point range for DL-3-Ureidoisobutyric acid is 177178 C.

Q: What is the molecular formula of DL-3-Ureidoisobutyric acid?

A: The molecular formula of DL-3-Ureidoisobutyric acid is C5H10N2O3.

Q: What is the usage of DL-3-Ureidoisobutyric acid in medical applications?

A: DL-3-Ureidoisobutyric acid can be used to predict patients individual phenotypes of enzyme deficiencies in pyrimidine metabolism, which are associated with a risk for severe toxicity against the antineoplastic agent 5-fluorouracil (PMID: 12798197).

Tell us about your requirement